Androgen Deprivation Therapy For Prostate Cancer Linked To Decreased Survival In Older Men

Androgen deprivation therapy (ADT), in which an injectable or implanted medication is used to disrupt the body's ability to make testosterone, is a common treatment for prostate cancer but should not be used in men whose cancer has not spread beyond the prostate, according to a new study. The findings are important for men with longer life expectancies because the therapy exposes them to more adverse side effects, and it is associated with increased risk of death and deprives men of the opportunity for a cure by other methods. ADT is already known to have significant side effects such as heart disease, diabetes, increased weight gain and impotence; the new study suggests ADT may also lead to earlier death.   read more

Read the whole article on

More from